Suscribirse

PEDIATRIC URINARY TRACT INFECTION - 03/09/11

Doi : 10.1016/S0733-8627(05)70209-1 
Sally A. Santen, MD a, Michael F. Altieri, MD b
a Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, Tennesee (SAS) 
b Departments of Emergency Medicine and Pediatrics, George Washington, and Georgetown Universities, Washington, DC; and the Department of Pediatrics, Fairfax Hospital, Fairfax, Virginia (MFA) 

Resumen

Urinary tract infections (UTIs) are common in children, however, they are “sneaky and sly” because they frequently do not manifest as dysuria, as is common in adults.2, 30 The diagnosis of UTI should be considered in all infants and children who present to the emergency department (ED) with classic symptoms of UTI, as well as in those with nonspecific symptoms, including fever, vomiting, abdominal, or flank pain. The goal of early diagnosis and treatment of UTIs in the pediatric population is the prevention of the complications of bacteremia and renal scarring. Although the most severe complication of pyelonephritis, renal scarring with progression to end stage renal disease is rare, aggressive treatment and work-up of pediatric urinary tract infection is preventive.

UTI is a nonspecific phrase used to define an inflammatory response to bacterial invasion anywhere within the renal system. Bacteria is present within the urine, as well as other signs of infection (nitrates, pyuria), and the patient may have local (dysuria, frequency, urgency) or systemic symptoms (fever, myalgias, rigors, nausea, vomiting, abdominal, or flank pain). Asymptomatic bacteriuria is defined as bacterial growth in the urine without signs or symptoms of infection. UTIs are divided into two overlapping categories—uncomplicated lower tract infection of cystitis and urethritis and upper tract infections of ureteritis, pyelitis (upper collecting system), and pyelonephritis (renal parenchyma). In general, the presence of fever, systemic symptoms, or back pain with infected urine indicates the presence of upper tract infection. Reliance upon the presence of fever alone to indicate the presence of an upper tract infection is problematic because renal scanning fails to show that fever is a reliable marker for pyelonephritis.36 As well, studies that have analyzed fever as a marker for upper tract infection have shown a wide range of sensitivities (53%–84%) and specificities (44%–92%).9 Also complicating the diagnosis of upper tract infection is the fact that there is no “gold standard” test for pyelonephritis. In the past, antibody-coated bacteria, and more recently, renal nuclear scanning have been used as indicators of pyelonephritis. However, the utility of these tests is still limited.

This chapter will discuss the spectrum of infections that fall under the heading of UTI. The diagnostic approach and management of the pediatric patient will be addressed. Infection in adults is addressed elsewhere.

El texto completo de este artículo está disponible en PDF.

Esquema


 Address reprint requests to Sally A. Santen, MD, Department of Emergency Medicine, Vanderbilt University Medical Center, 703 Oxford House, Nashville, TN 37232–4700


© 2001  W. B. Saunders Company. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 19 - N° 3

P. 675-690 - août 2001 Regresar al número
Artículo precedente Artículo precedente
  • UNINARY TRACT INFECTION AND PYELONEPHRITIS
  • Otis Miller, Robin R. Hemphill
| Artículo siguiente Artículo siguiente
  • PROSTATITIS
  • William E. Lummus, Ian Thompson

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.